background preloader

February

Facebook Twitter

Urgency And Optimism: Corporate Culture The Michael J. Fox Foundation Way. Todd Sherer wants to put the Michael J.

Urgency And Optimism: Corporate Culture The Michael J. Fox Foundation Way

Fox Foundation (MJFF)--the world’s largest private funder of Parkinson’s Disease research--out of business. That may sound strange, especially considering that if Sherer achieves that goal as CEO of the Foundation, he’ll be out of a job. But it will also mean they’ve found a cure for Parkinson’s, a chronic, degenerative neurological disorder that affects one million people in the United States, and more than 5 million worldwide. To date, the MJFF has contributed more than $275 million toward its goal of finding a cure by focusing on innovation. And agility. As one of MJFF’s first in-house scientists, Sherer (who holds a PhD in neuroscience from the University of Virginia) is particularly keen on the new Fox Trial Finder, a tech tool that pairs Parkinson’s patients with clinical research trials--a vital component in the development of new treatments and ultimately a cure.

Making the Big Switch Fast Tracking--Even With Big Pharma Eye on the Prize. Cleveland Clinic Joins 23andMe, Michael J. Fox Foundation in Search for Genetic Clues to PD. One-Time Monthly In Tribute Team Fox Tweet HOME › Our Role & Impact › FoxFeed Blog The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.

Cleveland Clinic Joins 23andMe, Michael J. Fox Foundation in Search for Genetic Clues to PD

National Institutes of Health Receives $3 Billion Spending Boost March 22, 2018 The spending deal was released last night and the bill must be passed by this Friday, March 23. New $6 Million Program Looks at Causes of Parkinson's The Michael J. Ask the MD: Parkinson's Diagnosis and Biomarkers In the latest "Ask the MD" video, Dr. Senator Cory Booker (D-NJ) Tells PD Advocates: 'What You Do Matters' March 21, 2018 Senator Booker gave a keynote speech to nearly 300 advocates in Washington, D.C. for the 2018 Parkinson's Policy Forum.

Collaboration Most Ambitious Initiative toward a Cure March 20, 2018 The Lancet Neurology calls the AMP PD program the "most ambitious initiative so far to find a cure for Parkinson's. " Pharma Company Buys Up MJFF-funded Biotech and Motor Symptom Therapy March 19, 2018 March 14, 2018 Dr. Cleveland Clinic Joins 23andme In The Search For Genetic Clues To Parkinson’s Disease. February 14, 2012 In an effort to study the interactions between genomics and Parkinson’s disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson’s patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.

Cleveland Clinic Joins 23andme In The Search For Genetic Clues To Parkinson’s Disease

Currently, little is known about how genes relate to Parkinson’s disease, the effectiveness of treatments, or the natural course of the disease. The goal of this collaborative research effort – which also has support from the Michael J. Fox Foundation, the National Parkinson Foundation and the Parkinson's Institute – is to discover how genes and the environment influence Parkinson's disease. “We are aware of the limitations of today’s treatments, so we are always thinking about what we can do to advance the care of this incurable disease,” said Andre Machado, MD, PhD, Director of Cleveland Clinic’s Center for Neurological Restoration.

The Michael J. Fox Foundation Pilots Partnering Program Between Awardees and Industry.